{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:24:26Z","timestamp":1787739866689,"version":"build-2784847793"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lineage commitment and differentiation of mesenchymal stromal cells (MSCs) into osteoblasts <jats:italic>in vitro<\/jats:italic> is enhanced by a potent synthetic form of glucocorticoid (GC), dexamethasone (Dex). Paradoxically, when used chronically in patients, GCs exert negative effects on bone, a phenomenon known as glucocorticoid-induced osteoporosis in clinical practice. The mechanism on how GC differentially affects bone precursor cells to become mature osteoblasts during osteogenesis remains elusive. In this study, the dose and temporal regulation of Dex on MSC differentiation into osteoblasts were investigated. We found that continuous Dex treatment led to a net reduction of the maturation potential of differentiating osteoblasts. This phenomenon correlated with a decrease in glucocorticoid receptor (GR) expression, hastened degradation, and impaired sub cellular localization. Similarly, Histone Deacetylase 6 <jats:italic>(HDAC6)<\/jats:italic> expression was found to be regulated by Dex, co-localized with GR and this GR-HDAC6 complex occupied the promoter region of the osteoblast late marker osteocalcin (OCN). Combinatorial inhibition of HDAC6 and GR enhanced <jats:italic>OCN<\/jats:italic> expression. Together, the cross-talk between the Dex effector molecule GR and the inhibitory molecule HDAC6 provided mechanistic explanation of the bimodal effect of Dex during osteogenic differentiation of MSCs. These findings may provide new directions of research to combat glucocorticoid-induced osteoporosis.<\/jats:p>","DOI":"10.1038\/srep37371","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T10:20:43Z","timestamp":1480501243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs)"],"prefix":"10.1038","volume":"6","author":[{"given":"Marilyn G.","family":"Rimando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Hsiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ping","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Fung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shiuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Kuang-Sheng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"key":"BFsrep37371_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/17460751.1.4.539","volume":"1","author":"PJ Marie","year":"2006","unstructured":"Marie, P. J. & Fromigue, O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1, 539\u2013548 (2006).","journal-title":"Regen Med"},{"key":"BFsrep37371_CR2","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2741\/2296","volume":"12","author":"W Huang","year":"2007","unstructured":"Huang, W., Yang, S., Shao, J. & Li, Y. P. Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front Biosci 12, 3068\u20133092 (2007).","journal-title":"Front Biosci"},{"key":"BFsrep37371_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1402.081","volume":"1116","author":"RT Franceschi","year":"2007","unstructured":"Franceschi, R. T., Ge, C., Xiao, G., Roca, H. & Jiang, D. Transcriptional regulation of osteoblasts. Ann N Y Acad Sci 1116, 196\u2013207 (2007).","journal-title":"Ann N Y Acad Sci"},{"key":"BFsrep37371_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jcb.10369","volume":"88","author":"RT Franceschi","year":"2003","unstructured":"Franceschi, R. T. & Xiao, G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J Cell Biochem 88, 446\u2013454 (2003).","journal-title":"J Cell Biochem"},{"key":"BFsrep37371_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1432-1033.1990.tb15382.x","volume":"188","author":"E Green","year":"1990","unstructured":"Green, E., Todd, B. & Heath, D. Mechanism of glucocorticoid regulation of alkaline phosphatase gene expression in osteoblast-like cells. Eur J Biochem 188, 147\u2013153 (1990).","journal-title":"Eur J Biochem"},{"key":"BFsrep37371_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1210\/endo.134.1.8275945","volume":"134","author":"SL Cheng","year":"1994","unstructured":"Cheng, S. L., Yang, J. W., Rifas, L., Zhang, S. F. & Avioli, L. V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134, 277\u2013286 (1994).","journal-title":"Endocrinology"},{"key":"BFsrep37371_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2005.11.034","volume":"248","author":"M Eijken","year":"2006","unstructured":"Eijken, M. et al. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248, 87\u201393 (2006).","journal-title":"Mol Cell Endocrinol"},{"key":"BFsrep37371_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/B:HIJO.0000020883.33256.fe","volume":"35","author":"M Igarashi","year":"2004","unstructured":"Igarashi, M. et al. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol 35, 3\u201310 (2004).","journal-title":"J Mol Histol"},{"key":"BFsrep37371_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jss.2010.09.010","volume":"173","author":"JB Park","year":"2012","unstructured":"Park, J. B. The effects of dexamethasone, ascorbic acid, and beta-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res 173, 99\u2013104 (2012).","journal-title":"J Surg Res"},{"key":"BFsrep37371_CR10","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1359\/JBMR.040714","volume":"19","author":"BC Heng","year":"2004","unstructured":"Heng, B. C., Cao, T., Stanton, L. W., Robson, P. & Olsen, B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res 19, 1379\u20131394 (2004).","journal-title":"J Bone Miner Res"},{"key":"BFsrep37371_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3109\/14653249.2011.652735","volume":"14","author":"H Wang","year":"2012","unstructured":"Wang, H. et al. Dexamethasone has variable effects on mesenchymal stromal cells. Cytotherapy 14, 423\u2013430 (2012).","journal-title":"Cytotherapy"},{"key":"BFsrep37371_CR12","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1210\/endo.138.5.5117","volume":"138","author":"JB Lian","year":"1997","unstructured":"Lian, J. B. et al. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 138, 2117\u20132127 (1997).","journal-title":"Endocrinology"},{"key":"BFsrep37371_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jsbmb.2009.05.007","volume":"116","author":"D Hong","year":"2009","unstructured":"Hong, D. et al. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells. J Steroid Biochem Mol Biol 116, 86\u201392 (2009).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFsrep37371_CR14","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1359\/jbmr.1998.13.12.1822","volume":"13","author":"Y Ishida","year":"1998","unstructured":"Ishida, Y. & Heersche, J. N. Glucocorticoid-induced osteoporosis: both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation. J Bone Miner Res 13, 1822\u20131826 (1998).","journal-title":"J Bone Miner Res"},{"key":"BFsrep37371_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bone.2006.07.012","volume":"40","author":"S Ito","year":"2007","unstructured":"Ito, S., Suzuki, N., Kato, S., Takahashi, T. & Takagi, M. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone 40, 84\u201392 (2007).","journal-title":"Bone"},{"key":"BFsrep37371_CR16","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/art.23454","volume":"58","author":"W Yao","year":"2008","unstructured":"Yao, W. et al. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 58, 1674\u20131686 (2008).","journal-title":"Arthritis Rheum"},{"key":"BFsrep37371_CR17","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1096\/fj.08-106302","volume":"22","author":"Z Hamidouche","year":"2008","unstructured":"Hamidouche, Z. et al. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt\/beta-catenin signaling-dependent Runx2 expression. FASEB J 22, 3813\u20133822 (2008).","journal-title":"FASEB J"},{"key":"BFsrep37371_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbrc.2012.02.074","volume":"419","author":"Q He","year":"2012","unstructured":"He, Q. et al. TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes. Biochem Biophys Res Commun 419, 573\u2013577 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep37371_CR19","doi-asserted-by":"publisher","first-page":"e832","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li, J. et al. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation. Cell Death Dis 4, e832 (2013).","journal-title":"Cell Death Dis"},{"key":"BFsrep37371_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/rheumatology\/40.1.74","volume":"40","author":"S Walsh","year":"2001","unstructured":"Walsh, S., Jordan, G. R., Jefferiss, C., Stewart, K. & Beresford, J. N. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 40, 74\u201383 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"BFsrep37371_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley, R. H. & Cidlowski, J. A. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol 132, 1033\u20131044 (2013).","journal-title":"J Allergy Clin Immunol"},{"key":"BFsrep37371_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.steroids.2009.09.002","volume":"75","author":"NC Nicolaides","year":"2010","unstructured":"Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P. & Charmandari, E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75, 1\u201312 (2010).","journal-title":"Steroids"},{"key":"BFsrep37371_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-0854.2011.01288.x","volume":"13","author":"S Vandevyver","year":"2012","unstructured":"Vandevyver, S., Dejager, L. & Libert, C. On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 13, 364\u2013374 (2012).","journal-title":"Traffic"},{"key":"BFsrep37371_CR24","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/jbmr.5650080810","volume":"8","author":"N Morrison","year":"1993","unstructured":"Morrison, N. & Eisman, J. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J Bone Miner Res 8, 969\u2013975 (1993).","journal-title":"J Bone Miner Res"},{"key":"BFsrep37371_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0169-6009(91)90025-U","volume":"14","author":"D Lajeunesse","year":"1991","unstructured":"Lajeunesse, D., Kiebzak, G. M., Frondoza, C. & Sacktor, B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 14, 237\u2013250 (1991).","journal-title":"Bone Miner"},{"key":"BFsrep37371_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/art.20872","volume":"52","author":"N Leclerc","year":"2005","unstructured":"Leclerc, N., Noh, T., Khokhar, A., Smith, E. & Frenkel, B. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2\/Krox20-binding enhancer. Arthritis Rheum 52, 929\u2013939 (2005).","journal-title":"Arthritis Rheum"},{"key":"BFsrep37371_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1432-1033.1995.0183i.x","volume":"230","author":"Y Ogata","year":"1995","unstructured":"Ogata, Y. et al. Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 230, 183\u2013192 (1995).","journal-title":"Eur J Biochem"},{"key":"BFsrep37371_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1210\/me.2011-1287","volume":"26","author":"YY Zhang","year":"2012","unstructured":"Zhang, Y. Y. et al. Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis. Mol Endocrinol 26, 798\u2013808 (2012).","journal-title":"Mol Endocrinol"},{"key":"BFsrep37371_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2007.07.003","volume":"275","author":"O Kassel","year":"2007","unstructured":"Kassel, O. & Herrlich, P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol Cell Endocrinol 275, 13\u201329 (2007).","journal-title":"Mol Cell Endocrinol"},{"key":"BFsrep37371_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2010.12.003","volume":"474","author":"ME McGee-Lawrence","year":"2011","unstructured":"McGee-Lawrence, M. E. & Westendorf, J. J. Histone deacetylases in skeletal development and bone mass maintenance. Gene 474, 1\u201311 (2011).","journal-title":"Gene"},{"key":"BFsrep37371_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jcb.21486","volume":"102","author":"JJ Westendorf","year":"2007","unstructured":"Westendorf, J. J. Histone deacetylases in control of skeletogenesis. J Cell Biochem 102, 332\u2013340 (2007).","journal-title":"J Cell Biochem"},{"key":"BFsrep37371_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1359\/jbmr.071104","volume":"23","author":"ED Jensen","year":"2008","unstructured":"Jensen, E. D., Schroeder, T. M., Bailey, J., Gopalakrishnan, R. & Westendorf, J. J. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J Bone Miner Res 23, 361\u2013372 (2008).","journal-title":"J Bone Miner Res"},{"key":"BFsrep37371_CR33","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1210\/me.2006-0061","volume":"20","author":"HW Lee","year":"2006","unstructured":"Lee, H. W. et al. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol Endocrinol 20, 2432\u20132443 (2006).","journal-title":"Mol Endocrinol"},{"key":"BFsrep37371_CR34","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/MCB.01154-06","volume":"28","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 28, 1688\u20131701 (2008).","journal-title":"Mol Cell Biol"},{"key":"BFsrep37371_CR35","doi-asserted-by":"publisher","first-page":"28783","DOI":"10.1074\/jbc.M113.489732","volume":"288","author":"A Dudakovic","year":"2013","unstructured":"Dudakovic, A. et al. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation. J Biol Chem 288, 28783\u201328791 (2013).","journal-title":"J Biol Chem"},{"key":"BFsrep37371_CR36","first-page":"1","volume":"15","author":"MB Eslaminejad","year":"2013","unstructured":"Eslaminejad, M. B., Fani, N. & Shahhoseini, M. Epigenetic regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in culture. Cell J 15, 1\u201310 (2013).","journal-title":"Cell J"},{"key":"BFsrep37371_CR37","doi-asserted-by":"publisher","first-page":"184154","DOI":"10.1155\/2012\/184154","volume":"2012","author":"A Kretsovali","year":"2012","unstructured":"Kretsovali, A., Hadjimichael, C. & Charmpilas, N. Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. Stem Cells Int 2012, 184154 (2012).","journal-title":"Stem Cells Int"},{"key":"BFsrep37371_CR38","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1210\/endo-109-6-1975","volume":"109","author":"JA Cidlowski","year":"1981","unstructured":"Cidlowski, J. A. & Cidlowski, N. B. Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells. Endocrinology 109, 1975\u20131982 (1981).","journal-title":"Endocrinology"},{"key":"BFsrep37371_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1749-6632.1994.tb39238.x","volume":"746","author":"JC Webster","year":"1994","unstructured":"Webster, J. C. & Cidlowski, J. A. Downregulation of the glucocorticoid receptor. A mechanism for physiological adaptation to hormones. Ann N Y Acad Sci 746, 216\u2013220 (1994).","journal-title":"Ann N Y Acad Sci"},{"key":"BFsrep37371_CR40","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1089\/dna.1997.16.919","volume":"16","author":"T Meyer","year":"1997","unstructured":"Meyer, T., Gustafsson, J. A. & Carlstedt-Duke, J. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 16, 919\u2013927 (1997).","journal-title":"DNA Cell Biol"},{"key":"BFsrep37371_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.bone.2009.05.009","volume":"45","author":"MK Choo","year":"2009","unstructured":"Choo, M. K., Yeo, H. & Zayzafoon, M. NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 45, 579\u2013589 (2009).","journal-title":"Bone"},{"key":"BFsrep37371_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature01660","volume":"423","author":"S Harada","year":"2003","unstructured":"Harada, S. & Rodan, G. A. Control of osteoblast function and regulation of bone mass. Nature 423, 349\u2013355 (2003).","journal-title":"Nature"},{"key":"BFsrep37371_CR43","first-page":"3441","volume":"81","author":"E Canalis","year":"1996","unstructured":"Canalis, E. Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81, 3441\u20133447 (1996).","journal-title":"J Clin Endocrinol Metab"},{"key":"BFsrep37371_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/107632700300003323","volume":"7","author":"LD Buttery","year":"2001","unstructured":"Buttery, L. D. et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7, 89\u201399 (2001).","journal-title":"Tissue Eng"},{"key":"BFsrep37371_CR45","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6","volume":"80","author":"M Prince","year":"2001","unstructured":"Prince, M. et al. Expression and regulation of Runx2\/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 80, 424\u2013440 (2001).","journal-title":"J Cell Biochem"},{"key":"BFsrep37371_CR46","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1089\/ten.2004.10.1623","volume":"10","author":"BA Byers","year":"2004","unstructured":"Byers, B. A. & Garcia, A. J. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells. Tissue Eng 10, 1623\u20131632 (2004).","journal-title":"Tissue Eng"},{"key":"BFsrep37371_CR47","doi-asserted-by":"publisher","first-page":"42714","DOI":"10.1074\/jbc.M106033200","volume":"276","author":"AD Wallace","year":"2001","unstructured":"Wallace, A. D. & Cidlowski, J. A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276, 42714\u201342721 (2001).","journal-title":"J Biol Chem"},{"key":"BFsrep37371_CR48","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/S0021-9258(18)69104-5","volume":"263","author":"S Rosewicz","year":"1988","unstructured":"Rosewicz, S. et al. Mechanism of glucocorticoid receptor down-regulation by glucocorticoids. J Biol Chem 263, 2581\u20132584 (1988).","journal-title":"J Biol Chem"},{"key":"BFsrep37371_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/bies.950190210","volume":"19","author":"IJ McEwan","year":"1997","unstructured":"McEwan, I. J., Wright, A. P. & Gustafsson, J. A. Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 19, 153\u2013160 (1997).","journal-title":"Bioessays"},{"key":"BFsrep37371_CR50","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","volume":"18","author":"JJ Kovacs","year":"2005","unstructured":"Kovacs, J. J. et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 18, 601\u2013607 (2005).","journal-title":"Mol Cell"},{"key":"BFsrep37371_CR51","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1523\/JNEUROSCI.5634-11.2012","volume":"32","author":"J Espallergues","year":"2012","unstructured":"Espallergues, J. et al. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. J Neurosci 32, 4400\u20134416 (2012).","journal-title":"J Neurosci"},{"key":"BFsrep37371_CR52","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1074\/jbc.M109.072728","volume":"285","author":"MV Govindan","year":"2010","unstructured":"Govindan, M. V. Recruitment of cAMP-response element-binding protein and histone deacetylase has opposite effects on glucocorticoid receptor gene transcription. J Biol Chem 285, 4489\u20134510 (2010).","journal-title":"J Biol Chem"},{"key":"BFsrep37371_CR53","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1210\/endo.142.7.8306","volume":"142","author":"G Karsenty","year":"2001","unstructured":"Karsenty, G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology 142, 2731\u20132733 (2001).","journal-title":"Endocrinology"},{"key":"BFsrep37371_CR54","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0430973100","volume":"100","author":"SJ Haggarty","year":"2003","unstructured":"Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M. & Schreiber, S. L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100, 4389\u20134394 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep37371_CR55","doi-asserted-by":"publisher","first-page":"7982","DOI":"10.1128\/MCB.22.22.7982-7992.2002","volume":"22","author":"JJ Westendorf","year":"2002","unstructured":"Westendorf, J. J. et al. Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1\/WAF1 Promoter. Mol Cell Biol 22, 7982\u20137992 (2002).","journal-title":"Mol Cell Biol"},{"key":"BFsrep37371_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jcb.24646","volume":"115","author":"T Koromila","year":"2014","unstructured":"Koromila, T. et al. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells. J Cell Biochem 115, 27\u201333 (2014).","journal-title":"J Cell Biochem"},{"key":"BFsrep37371_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C","volume":"219","author":"P Ducy","year":"2000","unstructured":"Ducy, P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219, 461\u2013471 (2000).","journal-title":"Dev Dyn"},{"key":"BFsrep37371_CR58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/ncb2910","volume":"16","author":"WL Hwang","year":"2014","unstructured":"Hwang, W. L. et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol 16, 268\u2013280 (2014).","journal-title":"Nat Cell Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37371","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:17:28Z","timestamp":1672877848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37371"],"URL":"https:\/\/doi.org\/10.1038\/srep37371","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]},"assertion":[{"value":"1 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37371"}}